LivingGLP1
Study S000049

A Cohort Study of the Benefits of Bydureon in Customary Clinical Care in the United States

ClinicalTrials.gov record

Registration

Registration
NCT02974244
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
7000
Start
2014-10-28
Primary completion
2014-10-28
Lead sponsor
AstraZeneca
Conditions
Type 2 Diabetes
Interventions
DRUG:exenatide once weekly; DRUG:basal insulin
Results posted
FALSE

Registered primary outcomes

  • Changes from baseline in HbA1c (%) [one year post-index]
  • Changes from baseline in weight (kg) [one year post-index]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.